David A. Siegel I Teos Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 37,900 shares of ITOS stock, worth $283,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,900
Previous 18,200
108.24%
Holding current value
$283,113
Previous $270,000
42.96%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ITOS
# of Institutions
166Shares Held
36.6MCall Options Held
1.95MPut Options Held
374K-
Black Rock Inc. New York, NY3.73MShares$27.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.18MShares$23.8 Million0.45% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$22 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$20.5 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$18 Million2.09% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $266M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...